|
Avksentiev N.A., Makarov A.S., Makarova Yu.V., Pazukhina E.M., Sisigina N.N., Feoktistova O.A. Zaitseva E.E., Kuznetsov S.D., Pace A., Saitkulov K.I.
The social and economic burdens of HIV in the Russian Federation
|
№3 / 2022
|
|
Ladnaia N.N., Pokrovsky V.V., Sokolova E.V., Chekryzhova D.G., Kirzhanova V.V.
Prevalence of human immune deficiency virus infection in the territories of the Russian Federation in 2021
|
№3 / 2022
|
|
Stepanova E.V., Leonova O.N., Buzunova S.A.
Analysis of the established disability group in HIV-infected patients
|
№1 / 2022
|
|
Belyaeva V.V., Kozyrina N.V., Sokolova E.V., Semikova S.Yu., Galiullin N.I., Bekbolotov A.A., Beshimov A.T., Berdalieva T.Ch., Narkevich A.N., Lebedeva E.P., Suvorova Z.K., Khokhlova O.N., Shegai M.M.
HIV treatment adherence technology: analysis of communications in the specialist-patient system
|
№1 / 2022
|
|
Malashenko A.A., Krasnov K.A., Krasnov O.A.
A surgeon's tactics in the diagnosis of fractures in HIV-infected patients. a clinical case of clavicular tuberculous lesion with pathological fracture
|
№4 / 2021
|
|
Matievskaya N.V., Dolinskaya O.V.
Experience with a dual ART regimen in an elderly female patient with HIV infection
|
№4 / 2021
|
|
Sokolova E.V., Belyaeva V.V., Kozyrina N.V., Galiullin N.I., Semikova S.Yu., Beshimov A.T., Lebedeva E.P., Khoraskina E.А., Narkevich A.N., Gavrilova O.V., Suvorova Z.К., Khokhlova O.N.
Self-assessment of health status as a factor for the prediction of adherence to follow-up and treatment of HIV infection: results of correlation analysis
|
№4 / 2021
|
|
Kanestri V.G., Kravchenko A.V., Pokrovskaya A.V., Kulabukhova E.I., Kuimova U.A., Goliusova M.D., Kozyrina N.V., Shakhgildyan V.I., Yurin O.G.
Randomized, open-label, controlled, comparative study on switching HIV-infected patients with their antiretroviral therapy experience to a DTG and 3TC regimen: 96-weeks results
|
№4 / 2021
|
|
Kravchenko A.V., Kuimova U.A., Kanestri V.G., Goliusova M.D., Kulabukhova E.I.
The clinical course of HIV/COVID-19 co-infection and approaches to its therapy
|
№4 / 2021
|
|
Ladnaia N.N., Pokrovsky V.V., Sokolova E.V., Chekryzhova D.G.
Prevalence of HIV infection among injecting drug users in the Siberian Federal District
|
№4 / 2021
|
|
Orlova-Morozova E.A., Pronin A.Yu.
The use of doravirine as part of antiretroviral therapy regimens in patients with resistance mutations
|
№3 / 2021
|
|
Kravchenko A.V., Pokrovskaya A.V., Kuimova U.A., Kanestri V.G., Deulina M.O., Goliusova M.D., Kulabukhova E.I., Kozyrina N.V., Yurin O.G.
Results of treatment with a 60-week Russian ART regimen in patients with HIV infection
|
№3 / 2021
|
Русский
